CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Optimal Maintenance Strategy for First-Line Oxaliplatin-Containing Therapy with or without Bevacizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis
Toshikazu Moriwaki, Masahiko Gosho, Akinori Sugaya, Takeshi Yamada, Yoshiyuki Yamamoto, Ichinosuke Hyodo
    DOI: https://doi.org/10.4143/crt.2020.805

Excel Download

187P Optimal treatment strategy of first-line oxaliplatin (Oxa)- containing therapy in metastatic colorectal cancer (mCRC): A trial-level meta-analysis
Annals of Oncology. 2016;27:ix58-ix59   Crossref logo
Link1 Link2

Real-world Direct Health Care Costs for Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab-containing Regimens in First-line or First-line Through Second-line Therapy
Clinical Colorectal Cancer. 2017;16(4):386-396.e1   Crossref logo
Link1 Link2

Selection of Second-line Anti-angiogenic Agents After Failure of Bevacizumab-containing First-line Chemotherapy in Metastatic Colorectal Cancer
Clinical Colorectal Cancer. 2018;17(4):251-254   Crossref logo
Link1 Link2

Retrospective Analysis of S-1 plus Bevacizumab as Maintenance Therapy after Induction of S-1 and Oxaliplatin (SOX) plus Bevacizumab as First-Line Chemotherapy in Patients with Metastatic Colorectal Cancer
Journal of Cancer Therapy. 2020;11(02):35-43   Crossref logo
Link1 Link2

Optimal Use of FOLFOXIRI Plus Bevacizumab as First-Line Systemic Treatment in Metastatic Colorectal Cancer
Current Colorectal Cancer Reports. 2020;16(4):89-95   Crossref logo
Link1 Link2 Link3

The Clinical Efficacy of FOLFIRI and Bevacizumab in Combination as First-Line Therapy of Metastatic Colorectal Cancer
Clinical Colorectal Cancer. 2007;6(9):621-624   Crossref logo
Link1 Link2

Second-line chemotherapy with or without bevacizumab after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer
. 2021;   Crossref logo
Link1 Link2

Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer
Clinical Colorectal Cancer. 2018;17(4):e663-e669   Crossref logo
Link1 Link2

Comparison of Irinotecan and Oxaliplatin as the First-Line Therapies for Metastatic Colorectal Cancer: A Meta-analysis
. 2020;   Crossref logo
Link1 Link2

616 POSTER Safety analysis of first-line bevacizumab plus chemotherapy in patients with metastatic colorectal cancer (mCRC) participating in a US registry
European Journal of Cancer Supplements. 2005;3(2):173   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.